Gilead Sciences Photos

Gilead Alberta ULC

+ Add Photo

Gilead Sciences Reviews

172 Reviews
2.7
172 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Gilead Sciences Chairman & CEO John C. Martin
John C. Martin
99 Ratings
  1.  

    very good all around

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Gilead Sciences full-time for more than a year

    Pros

    good benefit, nice office,

    Cons

    lean- stressful work environment
    campus is expanding and it's hard to go from one building to another

    Recommends
    Approves of CEO

Gilead Sciences Interviews

Updated Aug 17, 2014
Updated Aug 17, 2014

Interview Experience

Interview Experience

65%
28%
6%

Getting an Interview

Getting an Interview

40%
32%
11%

Interview Difficulty

3.1
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Intern Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied online. The process took 4+ weeks - interviewed at Gilead Sciences.

    Interview Details

    I applied online to position. I had phone interviews with recruiters first and subsequently with the hiring manager for the position. Then, I was invited onsite for an in person interview with the team members. All in all, the process took about four weeks. I was always made aware of next steps, etc.

    No Offer
    Neutral Experience
    Difficult Interview

Gilead Sciences Awards & Accolades

Something missing? Add an award
100 Fastest Growing Companies, Fortune, 2009
America's Top Companies, Forbes, 2009
Show More

Additional Info

Edit Profile
Website www.gilead.com
Headquarters Foster City, CA
Size 5000+ Employees
Founded 1987
Type Company - Public (GILD)
Industry Biotech & Pharmaceuticals
Revenue $10+ billion (USD) per year

Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes Truvada, a combination of two of its other drugs, Viread and Emtriva. It co-promotes another HIV treatment, called Atripla, in the US and Europe with Bristol-Myers Squibb. Other products on the market include AmBisome, used to treat systemic fungal infections such as those that accompany AIDS; Vistide, for AIDS-related eye infections; and hepatitis B antiviral Hepsera. Beyond HIV/AIDS, Gilead also markets Letairis, a... More

Worked for Gilead Sciences? Contribute to the Community!